LiqTech Q2 Loss Widens, But Cash Infusion Removes Going Concern Warning

summarizeSummary

LiqTech reported a wider Q2 loss but removed its going concern warning after a $18M capital raise. Cash stands at $15.7M, though the stock trades below $1 and faces Nasdaq delisting risk.

check_boxKey Events · Earnings and Guidance · LIQT

• Q2 Loss Widens

  Net loss of $3.05M on revenue of $4.36M, compared to a $2.16M loss on $4.96M revenue in Q2 2025. Operating loss increased to $2.33M from $2.11M.

• Going Concern Warning Removed

  Management states cash of $15.66M and projected operations are sufficient for the next 12 months, removing the going concern qualification that existed in prior filings.

• Material Weakness Persists

  Disclosure controls and procedures remain ineffective due to material weaknesses in internal controls over financial reporting, with remediation efforts ongoing.

• Nasdaq Delisting Risk

  Stock price at $0.76 remains below the $1.00 minimum bid requirement; a deficiency notice was received on July 21, 2026, giving the company until January 2027 to regain compliance.

auto_awesomeAnalysis · LIQT · Technology

LiqTech's Q2 2026 results show a net loss of $3.05 million on revenue of $4.36 million, with operating losses deepening year-over-year. However, the company's June capital raise of $18 million net has transformed its balance sheet, boosting cash to $15.66 million and eliminating the going concern warning that had hung over the stock. Management now states cash is sufficient for the next 12 months. The material weakness in internal controls remains unremediated, a persistent risk. The stock trades at $0.76, well below the $1.00 offering price from June, and faces a Nasdaq delisting threat after receiving a deficiency notice in July.